Semalytix

Semalytix applies artificial intelligence and language processing to unstructured text for pharmaceutical companies. Its main product is Project Atlas, an agentic AI platform that analyses what patients say publicly and turns it into steady intelligence.

What Semalytix offers

• Project Atlas — monitors patient experience data across 26 languages and 144 countries every day.
• Safety Sentinel — a pharmacovigilance agent that watches public digital discussion for safety signals.
• Outbreak Sentinel — a radar for respiratory outbreaks.
• Traceable evidence — each signal links back to a verified patient statement.
• Objective-aware analysis — the platform is briefed on a brand, asset or therapeutic area so answers fit each team.

Who it works with

The company says the platform is used by large pharmaceutical firms in medical, commercial, health economics and pharmacovigilance teams. It describes a compliance-first design with supervised guardrails.